Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 5947859, 13 pages
https://doi.org/10.1155/2017/5947859
Review Article

Akt/mTOR Role in Human Foetoplacental Vascular Insulin Resistance in Diseases of Pregnancy

1Cellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, 8330024 Santiago, Chile
2Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen (UMCG), 9700 RB Groningen, Netherlands
3Department of Physiology, Faculty of Pharmacy, Universidad de Sevilla, 41012 Seville, Spain
4Department of Basic Sciences, Faculty of Sciences, Universidad del Bío-Bío, 3780000 Chillán, Chile
5Vascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 4070386 Concepción, Chile
6Institute of Biochemistry and Microbiology, Science Faculty, Universidad Austral de Chile, 5110566 Valdivia, Chile
7Metabolic Diseases Research Laboratory, Center of Research, Development and Innovation in Health-Aconcagua Valley, School of Medicine, Faculty of Medicine, Universidad de Valparaíso, San Felipe Campus, 2172972 San Felipe, Chile
8University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine and Biomedical Sciences, University of Queensland, Herston, Brisbane, QLD 4029, Australia

Correspondence should be addressed to Luis Sobrevia

Received 1 June 2017; Accepted 15 August 2017; Published 14 September 2017

Academic Editor: Christian Wadsack

Copyright © 2017 Roberto Villalobos-Labra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association (ADA), “Classification and diagnosis of diabetes,” Diabetes Care, vol. 40, pp. S11–S24, 2017. View at Google Scholar
  2. World Health Organization (WHO), “Global status report on noncommunicable diseases 2014,” World Health, vol. 176, 2014. View at Google Scholar
  3. R. Muniyappa and J. R. Sowers, “Role of insulin resistance in endothelial dysfunction,” Reviews in Endocrine & Metabolic Disorders, vol. 14, pp. 5–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Silva, M. Subiabre, J. Araos et al., “Insulin/adenosine axis linked signalling,” Molecular Aspects of Medicine, vol. 55, pp. 45–61, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. A. D. Sonagra, S. M. Biradar, K. Dattatreya, and D. S. J. Murthy, “Normal pregnancy- a state of insulin resistance,” Journal of Clinical and Diagnostic Research, vol. 8, pp. CC01–CC03, 2014. View at Publisher · View at Google Scholar
  6. K. J. Mather, H. O. Steinberg, and A. D. Baron, “Insulin resistance in the vasculature,” The Journal of Clinical Investigation, vol. 123, pp. 1003-1004, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. B. Fox and T. Y. Khong, “Lack of innervation of human umbilical cord. An immunohistological and histochemical study,” Placenta, vol. 11, pp. 59–62, 1990. View at Google Scholar
  8. M. S. Hanson, A. H. Stephenson, E. A. Bowles, and R. S. Sprague, “Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase,” Experimental Biology and Medicine, vol. 235, pp. 256–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Sobrevia, R. Salsoso, T. Sáez, C. Sanhueza, F. Pardo, and A. Leiva, “Insulin therapy and fetoplacental vascular function in gestational diabetes mellitus,” Experimental Physiology, vol. 100, pp. 231–238, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Salsoso, M. Farías, J. Gutiérrez et al., “Adenosine and preeclampsia,” Molecular Aspects of Medicine, vol. 55, pp. 126–139, 2017. View at Publisher · View at Google Scholar
  11. L. Antonioli, C. Blandizzi, B. Csóka, P. Pacher, and G. Haskó, “Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations,” Nature Reviews. Endocrinology, vol. 11, pp. 228–241, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Pardo, R. Villalobos-Labra, D. I. Chiarello et al., “Molecular implications of adenosine in obesity,” Molecular Aspects of Medicine, vol. 55, pp. 90–101, 2017. View at Publisher · View at Google Scholar
  13. F. Westermeier, T. Sáez, P. Arroyo et al., “Insulin receptor isoforms: an integrated view focused on gestational diabetes mellitus,” Diabetes/Metabolism Research and Reviews, vol. 32, pp. 350–365, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Mosthaf, K. Grako, T. J. Dull, L. Coussens, A. Ullrich, and M. C. DA, “Functionally distinct insulin receptors generated by tissue-specific alternative splicing,” The EMBO Journal, vol. 9, pp. 2409–2413, 1990. View at Google Scholar
  15. J. Boucher, A. Kleinridders, and C. R. Kahn, “Insulin receptor signaling in normal and insulin-resistant states,” Cold Spring Harbor Perspectives in Biology, vol. 6, article a009191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. K. S. Ravichandran, “Signaling via Shc family adapter proteins,” Oncogene, vol. 20, pp. 6322–6330, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Ong, Y. R. Hadari, N. Gotoh, G. R. Guy, J. Schlessinger, and I. Lax, “Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, pp. 6074–6079, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Sobrevia, R. Salsoso, B. Fuenzalida et al., “Insulin is a key modulator of fetoplacental endothelium metabolic disturbances in gestational diabetes mellitus,” Frontiers in Physiology, vol. 7, p. 119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Roberts, L. M. Bodnar, T. E. Patrick, and R. W. Powers, “The role of obesity in preeclampsia,” Pregnancy Hypertens, vol. 1, pp. 6–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Salsoso, E. Guzmán-Gutiérrez, T. Sáez et al., “Insulin restores l-arginine transport requiring adenosine receptors activation in umbilical vein endothelium from late-onset preeclampsia,” Placenta, vol. 36, pp. 287–296, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Westermeier, C. Salomón, M. González et al., “Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium,” Diabetes, vol. 60, pp. 1677–1687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Wang, R. Huang, B. Yu et al., “Higher fetal insulin resistance in Chinese pregnant women with gestational diabetes mellitus and correlation with maternal insulin resistance,” PLoS One, vol. 8, article e59845, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Pardo, L. Silva, T. Sáez et al., “Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction,” International Journal of Obesity, vol. 39, pp. 1264–1273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Karar and A. Maity, “PI3K/AKT/mTOR pathway in angiogenesis,” Frontiers in Molecular Neuroscience, vol. 4, p. 51, 2011. View at Publisher · View at Google Scholar
  25. A. Tzatsos, “Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR,” The Journal of Biological Chemistry, vol. 284, pp. 22525–22534, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. J. Kim, M. A. DeStefano, W. J. Oh et al., “mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8,” Molecular Cell, vol. 48, pp. 875–887, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Mihaylova and R. J. Shaw, “The AMPK signalling pathway coordinates cell growth, autophagy and metabolism,” Nature Cell Biology, vol. 13, pp. 1016–1023, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Fisslthaler and I. Fleming, “Activation and signaling by the AMP-activated protein kinase in endothelial cells,” Circulation Research, vol. 105, pp. 114–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. G. Hardie and F. A. RossS. A. Hawley, “AMPK: a nutrient and energy sensor that maintains energy homeostasis,” Nature Reviews. Molecular Cell Biology, vol. 13, pp. 251–262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Fleming, “Molecular mechanisms underlying the activation of eNOS,” Pflugers Archiv-European Journal of Physiology, vol. 459, pp. 793–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Ido, D. Carling, and N. Ruderman, “Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation,” Diabetes, vol. 51, pp. 159–167, 2002. View at Google Scholar
  32. F. Andreozzi, E. Laratta, A. Sciacqua, F. Perticone, and G. Sesti, “Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells,” Circulation Research, vol. 94, pp. 1211–1218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. V. De Nigris, G. Pujadas, L. La Sala, R. Testa, S. Genovese, and A. Ceriello, “Short-term high glucose exposure impairs insulin signaling in endothelial cells,” Cardiovascular Diabetology, vol. 14, p. 114, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Pellegatta, A. L. Catapano, L. Luzi, and I. Terruzzi, “In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism,” Journal of Cardiovascular Pharmacology, vol. 47, pp. 643–649, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. L. Hwang, Y. T. Jeong, X. Li et al., “Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle,” British Journal of Pharmacology, vol. 169, pp. 69–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. L. A. Barbour, C. E. McCurdy, T. L. Hernandez, J. P. Kirwan, P. M. Catalano, and J. E. Friedman, “Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes,” Diabetes Care, vol. 30, pp. 112–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Ruan and L. Q. Dong, “Adiponectin signaling and function in insulin target tissues,” Journal of Molecular Cell Biology, vol. 8, pp. 101–109, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Yadav, M. A. Kataria, V. Saini, and A. Yadav, “Role of leptin and adiponectin in insulin resistance,” Clinica Chimica Acta, vol. 417, pp. 80–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Surapisitchat, R. J. Hoefen, X. Pi, M. Yoshizumi, C. Yan, and B. C. Berk, “Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, pp. 6476–6481, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M. F. White, “The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307,” The Journal of Biological Chemistry, vol. 275, pp. 9047–9054, 2000. View at Google Scholar
  41. Y. H. Lee, J. Giraud, R. J. Davis, and M. F. White, “c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade,” The Journal of Biological Chemistry, vol. 278, pp. 2896–2902, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Hiratani, T. Haruta, A. Tani, J. Kawahara, I. Usui, and M. Kobayashi, “Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1,” Biochemical and Biophysical Research Communications, vol. 335, pp. 836–842, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. P. Kirwan, S. Hauguel-De Mouzon, J. Lepercq et al., “TNF-alpha is a predictor of insulin resistance in human pregnancy,” Diabetes, vol. 51, pp. 2207–2213, 2002. View at Google Scholar
  44. A. S. Lihn, S. B. Pedersen, and B. Richelsen, “Adiponectin: action, regulation and association to insulin sensitivity,” Obesity Reviews, vol. 6, pp. 13–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. S. S. Huda, L. E. Brodie, and N. Sattar, “Obesity in pregnancy: prevalence and metabolic consequences,” Seminars in Fetal & Neonatal Medicine, vol. 15, pp. 70–76, 2010. View at Publisher · View at Google Scholar
  46. G. Winkler, K. Cseh, E. Baranyi et al., “Tumor necrosis factor system in insulin resistance in gestational diabetes,” Diabetes Research and Clinical Practice, vol. 56, pp. 93–99, 2002. View at Google Scholar
  47. A. Molvarec, A. Szarka, S. Walentin et al., “Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia,” Reproductive Biology and Endocrinology, vol. 9, p. 124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Askari, G. Tykodi, J. Liu, and S. Dagogo-Jack, “Fasting plasma leptin level is a surrogate measure of insulin sensitivity,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, pp. 3836–3843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Bouloumie, T. Marumo, M. Lafontan, and R. Busse, “Leptin induces oxidative stress in human endothelial cells,” The FASEB Journal, vol. 13, pp. 1231–1238, 1999. View at Google Scholar
  50. A. Kautzky-Willer, G. Pacini, A. Tura et al., “Increased plasma leptin in gestational diabetes,” Diabetologia, vol. 44, pp. 164–172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Atègbo, O. Grissa, A. Yessoufou et al., “Modulation of adipokines and cytokines in gestational diabetes and macrosomia,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, pp. 4137–4143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Sibai, G. Dekker, and M. Kupferminc, “Pre-eclampsia,” Lancet (London, England), vol. 365, pp. 785–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. A. L. Tranquilli, M. A. Brown, G. G. Zeeman, G. Dekker, and B. M. Sibai, “The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP),” Pregnancy Hypertens, vol. 3, pp. 44–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. American College of Obstetrics and Gynecology (ACOG), “Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy,” Obstetrics and Gynecology, vol. 122, pp. 1122–1131, 2013. View at Publisher · View at Google Scholar
  55. F. R. Abhari, M. Ghanbari Andarieh, A. Farokhfar, and S. Ahmady, “Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women,” BioMed Research International, vol. 2014, Article ID 140851, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Scioscia, S. A. Karumanchi, D. Goldman-Wohl, and P. Y. Robillard, “Endothelial dysfunction and metabolic syndrome in preeclampsia: an alternative viewpoint,” Journal of Reproductive Immunology, vol. 108, pp. 42–47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Szabo, M. Mody, R. Romero et al., “Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome,” Pathology Oncology Research, vol. 21, pp. 659–668, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Zhang, Y. Han, and Y. Han, “Serum soluble endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction,” Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, vol. 22, pp. 371–374, 2010. View at Google Scholar
  59. T. J. Kaitu’u-Lino, R. Hastie, N. J. Hannan et al., “Loss of Akt increases soluble endoglin release from endothelial cells but not placenta,” Pregnancy Hypertens, vol. 6, pp. 95–102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  60. N. L. Huang, S. H. Chiang, C. H. Hsueh, Y. J. Liang, Y. J. Chen, and L. P. Lai, “Metformin inhibits TNF-α-induced IκB kinase phosphorylation, IκB-α degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation,” International Journal of Cardiology, vol. 134, pp. 169–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. J. Cudmore, S. Ahmad, S. Sissaoui et al., “Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1,” European Heart Journal, vol. 33, pp. 1150–1158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. A. H. Shaamash, E. D. Elsnosy, A. M. Makhlouf, M. M. Zakhari, O. A. Ibrahim, and E L.-d. HM, “Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia,” International Journal of Gynaecology and Obstetrics, vol. 68, pp. 207–214, 2000. View at Google Scholar
  63. S. Demircan Sezer, M. Küçük, S. Nergiz Avcıoğlu et al., “Comparison of maternal and umbilical cord blood HIF-1α and nitric oxide levels in early and late onset preeclamptic pregnancies,” Gynecological Endocrinology, vol. 31, pp. 945–948, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. J. A. Gonzalez-Garrido Chem, I. M. Olivares-Corichi, J. M. Tovar-Rodriguez et al., “Influence of the AT(2) receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia,” Journal of Human Hypertension, vol. 27, pp. 355–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Scioscia, K. Gumaa, S. Kunjara et al., “Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, pp. 709–717, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. S. E. Maynard and S. A. Karumanchi, “Angiogenic factors and preeclampsia,” Seminars in Nephrology, vol. 31, pp. 33–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Rana, S. A. Karumanchi, and M. D. Lindheimer, “Angiogenic factors in diagnosis, management, and research in preeclampsia,” Hypertension, vol. 63, pp. 198–202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Verdonk, L. Saleh, S. Lankhorst et al., “Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression,” Hypertension, vol. 65, pp. 1316–1323, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Cindrova-Davies, D. A. Sanders, G. J. Burton, and D. S. Charnock-Jones, “Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling,” Cardiovascular Research, vol. 89, pp. 671–679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. B. D. Cuevas, Y. Lu, M. Mao et al., “Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase,” The Journal of Biological Chemistry, vol. 276, pp. 27455–27461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. R. B. Orcy, S. Schroeder, S. Hofmeister Martins-Costa et al., “Signalization of Akt/PKB in the placenta, skeletal muscle and adipose tissue of preeclampsia patients,” Gynecologic and Obstetric Investigation, vol. 66, pp. 231–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Y. Chu, W. M. Callaghan, S. Y. Kim et al., “Maternal obesity and risk of gestational diabetes mellitus,” Diabetes Care, vol. 30, pp. 2070–2076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Bellamy, J.-P. Casas, A. D. Hingorani, and D. Williams, “Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis,” Lancet, vol. 373, pp. 1773–1779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. P. M. Catalano, E. D. Tyzbir, R. R. Wolfe et al., “Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes,” The American Journal of Physiology, vol. 264, pp. E60–E67, 1993. View at Google Scholar
  75. B. L. Silverman, B. E. Metzger, N. H. Cho, and C. A. Loeb, “Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism,” Diabetes Care, vol. 18, pp. 611–617, 1995. View at Google Scholar
  76. C. Y. Sanhal, H. K. Daglar, O. Kara, D. Uygur, and A. Yucel, “Assessment of fetal myocardial performance index in women with pregestational and gestational diabetes mellitus,” The Journal of Obstetrics and Gynaecology Research, vol. 43, pp. 65–72, 2017. View at Publisher · View at Google Scholar · View at Scopus
  77. J. S. Sheffield, E. L. Butler-Koster, B. M. Casey, M. I. DD, and K. J. Leveno, “Maternal diabetes mellitus and infant malformations,” Obstetrics and Gynecology, vol. 100, pp. 925–930, 2002. View at Google Scholar
  78. J. L. Nold and M. K. Georgieff, “Infants of diabetic mothers,” Pediatric Clinics of North America, vol. 51, pp. 619–637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. D. Mitanchez, A. Burguet, and U. Simeoni, “Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health,” The Journal of Pediatrics, vol. 164, pp. 445–450, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Westermeier, C. Salomón, M. Farías et al., “Insulin requires normal expression and signaling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium,” The FASEB Journal, vol. 29, pp. 37–49, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Peleli, B. Fredholm, L. Sobrevia, and M. Carlström, “Pharmacological targeting of adenosine receptor signalling,” Molecular Aspects of Medicine, vol. 55, pp. 4–8, 2017. View at Publisher · View at Google Scholar
  82. E. Guzmán-Gutiérrez, A. Armella, F. Toledo, F. Pardo, A. Leiva, and L. Sobrevia, “Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium,” Purinergic Signal, vol. 12, pp. 175–190, 2016. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Pérez-Pérez, J. L. Maymo, Y. P. Gambino et al., “Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: possible role of leptin,” Hormone and Metabolic Research, vol. 45, pp. 436–442, 2013a. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Yao, Y. Zhang, D. Wang et al., “GDM-induced macrosomia is reversed by Cav-1 via AMPK-mediated fatty acid transport and GLUT1-mediated glucose transport in placenta,” PLoS One, vol. 12, 2017. View at Publisher · View at Google Scholar
  85. M. T. Coughlan, K. Oliva, H. M. Georgiou, J. M. Permezel, and G. E. Rice, “Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus,” Diabetic Medicine, vol. 18, pp. 921–927, 2001. View at Google Scholar
  86. M. T. Coughlan, M. Permezel, H. M. Georgiou, and G. E. Rice, “Repression of oxidant-induced nuclear factor-κB activity mediates placental cytokine responses in gestational diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, pp. 3585–3594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Pérez-Pérez, J. Maymó, Y. Gambino et al., “Insulin enhances leptin expression in human trophoblastic cells,” Biology of Reproduction, vol. 89, p. 20, 2013b. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Martino, S. Sebert, M. T. Segura et al., “Maternal body weight and gestational diabetes differentially influence placental and pregnancy outcomes,” The Journal of Clinical Endocrinology and Metabolism, vol. 101, pp. 59–68, 2016. View at Google Scholar
  89. R. McManus, K. Summers, B. De Vrijer, N. Cohen, A. Thompson, and I. Giroux, “Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin D and adipocytokine concentrations in pregnancies with and without gestational diabetes,” Clinical Endocrinology, vol. 80, pp. 635–641, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Colomiere, M. Permezel, C. Riley, G. Desoye, and M. Lappas, “Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus,” European Journal of Endocrinology, vol. 160, pp. 567–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Subiabre, L. Silva, R. Villalobos-Labra et al., “Maternal insulin therapy does not restore foetoplacental endothelial dysfunction in gestational diabetes mellitus,” Biochimica et Biophysica Acta Molecular Basis of Disease, 2017. View at Publisher · View at Google Scholar
  92. S. H. Koning, K. Hoogenberg, K. A. Scheuneman et al., “Neonatal and obstetric outcomes in diet- and insulin-treated women with gestational diabetes mellitus: a retrospective study,” BMC Endocrine Disorders, vol. 16, p. 52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  93. R. T. McGrath, S. J. Glastras, S. Hocking, and G. R. Fulcher, “Use of metformin earlier in pregnancy predicts supplemental insulin therapy in women with gestational diabetes,” Diabetes Research and Clinical Practice, vol. 116, pp. 96–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  94. B. Persson, M. Stangenberg, U. Hansson, and E. Nordlander, “Gestational diabetes mellitus (GDM). Comparative evaluation of two treatment regimens, diet versus insulin and diet,” Diabetes, vol. 34, pp. 101–105, 1985. View at Google Scholar
  95. O. Verier-Mine, “Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review,” Diabetes & Metabolism, vol. 36, pp. 595–616, 2010. View at Publisher · View at Google Scholar
  96. S. M. Grundy, H. B. Brewer, J. I. Cleeman, S. C. Smith Jr., C. Lenfant, and American Heart Association, National Heart, Lung, and Blood Institute, “Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American Heart Association Conference on Scientific Issues Related to Definition,” Circulation, vol. 109, pp. 433–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. P. M. Catalano, L. Presley, J. Minium, and S. Hauguel-de Mouzon, “Fetuses of obese mothers develop insulin resistance in utero,” Diabetes Care, vol. 32, pp. 1076–1080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. L. E. Simental-Mendía, A. Castañeda-Chacón, M. Rodríguez-Morán, and F. Guerrero-Romero, “Birth-weight, insulin levels, and HOMA-IR in newborns at term,” BMC Pediatrics, vol. 12, p. 94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Pirkola, A. Pouta, A. Bloigu et al., “Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus,” Diabetes Care, vol. 33, pp. 1115–1121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Gaillard, E. A. P. Steegers, L. Duijts et al., “Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the generation R study,” Hypertension, vol. 63, pp. 683–691, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. K. M. Thakali, J. Saben, J. B. Faske et al., “Maternal pregravid obesity changes gene expression profiles toward greater inflammation and reduced insulin sensitivity in umbilical cord,” Pediatric Research, vol. 76, pp. 202–210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. J. Saben, F. Lindsey, Y. Zhong et al., “Maternal obesity is associated with a lipotoxic placental environment,” Placenta, vol. 35, pp. 171–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. N. Jansson, F. J. Rosario, F. Gaccioli et al., “Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, pp. 105–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Jansson, A. Nilsfelt, M. Gellerstedt et al., “Maternal hormones linking maternal body mass index and dietary intake to birth weight,” The American Journal of Clinical Nutrition, vol. 87, pp. 1743–1749, 2008. View at Google Scholar
  105. J. Saben, Y. Zhong, H. Gomez-Acevedo et al., “Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity,” The American Journal of Physiology, vol. 305, pp. E1–E14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. E. Paré, S. Parry, T. F. McElrath, D. Pucci, A. Newton, and K. H. Lim, “Clinical risk factors for preeclampsia in the 21st century,” Obstetrics and Gynecology, vol. 124, pp. 763–770, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. T.-H. Hung and T.-T. Hsieh, “Pregestational body mass index, gestational weight gain, and risks for adverse pregnancy outcomes among Taiwanese women: a retrospective cohort study,” Taiwanese Journal of Obstetrics & Gynecology, vol. 55, pp. 575–581, 2016. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Dieber-Rotheneder, S. Beganovic, G. Desoye, U. Lang, and M. Cervar-Zivkovic, “Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes,” Life Sciences, vol. 91, pp. 710–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. W. Xiang, H. Chen, X. Xu, M. Zhang, and R. Jiang, “Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia,” International Journal of Gynaecology and Obstetrics, vol. 89, pp. 103–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. G. D. Ferreira, R. B. Orcy, S. H. Martins-Costa et al., “Insulin stimulation of Akt/PKB phosphorylation in the placenta of preeclampsia patients,” São Paulo Medical Journal, vol. 129, pp. 387–391, 2011. View at Google Scholar
  111. C. Escudero, P. Bertoglia, M. Hernadez et al., “Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia,” Purinergic Signal, vol. 9, pp. 215–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. X. Wang, N. Athayde, and B. Trudinger, “Maternal plasma from pregnant women with umbilical placental vascular disease does not affect endothelial cell mRNA expression of nitric oxide synthase,” Journal of the Society for Gynecologic Investigation, vol. 11, pp. 149–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Alonso, C. González Del Rey, A. Navarro, J. Tolivia, and C. G. González, “Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta,” Gynecological Endocrinology, vol. 22, pp. 526–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. L. Sati, B. Soygur, and C. Celik-Ozenci, “Expression of mammalian target of rapamycin and downstream targets in normal and gestational diabetic human term placenta,” Reproductive Sciences, vol. 23, pp. 324–332, 2016. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Chen, H. Chen, Y. Wu, B. Liu, Z. Li, and Z. Wang, “Adiponectin exerts antiproliferative effect on human placenta via modulation of the JNK/c-jun pathway,” International Journal of Clinical and Experimental Pathology, vol. 7, pp. 2894–2904, 2014. View at Google Scholar
  116. C. Marseille-Tremblay, M. Ethier-Chiasson, J.-C. Forest et al., “Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta,” Molecular Reproduction and Development, vol. 75, pp. 1054–1062, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Subiabre, R. Salsoso, R. Villalobos-Labra et al., “Insulin therapy fails to reverse the human foetoplacental endothelial dysfunction in gestational diabetes mellitus,” Placenta, vol. 51, pp. 117-118, 2017. View at Google Scholar
  118. C. Salomón, F. Westermeier, C. Puebla et al., “Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin,” PLoS One, vol. 7, article e40578, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. K. E. Brett, Z. M. Ferraro, M. Holcik, and K. B. Adamo, “Placenta nutrient transport-related gene expression: the impact of maternal obesity and excessive gestational weight gain,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 29, pp. 1399–1405, 2016. View at Publisher · View at Google Scholar · View at Scopus